![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61P 35/00 | |
A61K 31/44 | |||
A61K 31/506 |
(11) | Patento numeris | 2906294 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 13762992.9 |
Europos patento paraiškos padavimo data | 2013-09-13 | |
(97) | Europos patento paraiškos paskelbimo data | 2015-08-19 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2018-04-18 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/EP2013/002747 |
Data | 2013-09-13 |
(87) | Numeris | WO 2014/056566 |
Data | 2014-04-17 |
(30) | Numeris | Data | Šalis |
12007039 | 2012-10-11 | EP |
(72) |
BLADT, Friedhelm, DE
FRIESE-HAMIM, Manja, DE
|
(73) |
Merck Patent GmbH,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
(54) | COMBINATION OF A 6-OXO-1,6-DIHYDRO-PYRIDAZINE DERIVATIVE HAVING ANTI-CANCER ACTIVITY WITH A MEK INHIBITOR |
COMBINATION OF A 6-OXO-1,6-DIHYDRO-PYRIDAZINE DERIVATIVE HAVING ANTI-CANCER ACTIVITY WITH A MEK INHIBITOR |